HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Judith K Evans Selected Research

Aprepitant (Emend)

2/2009Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
10/2007Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant.
7/2007Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects.
5/2007A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
8/2005Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.
6/2005The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
10/2004Aprepitant: an oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy.
3/2004Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity.
11/2003The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
6/2003Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Judith K Evans Research Topics

Disease

12Nausea
02/2009 - 01/2002
12Vomiting
02/2009 - 06/2002
2Migraine Disorders (Migraine)
03/2009 - 01/2002
2Headache (Headaches)
03/2009 - 01/2002
2Postoperative Nausea and Vomiting (PONV)
10/2007 - 05/2007
2Neoplasms (Cancer)
06/2003 - 05/2003
1Wrist Fractures
08/2009
1Breast Neoplasms (Breast Cancer)
08/2009
1Postmenopausal Osteoporosis
08/2009
1Febrile Neutropenia
02/2009
1Hemorrhage
08/2003
1Rheumatoid Arthritis
08/2003
1Osteoarthritis
08/2003
1Ulcer
08/2003
1Low Back Pain (Lumbago)
08/2003
1Infections
05/2003
1Dizziness (Lightheadedness)
01/2002
1Asthenia
01/2002
1Pain (Aches)
01/2002
1Sleepiness
01/2002
1Fatigue
01/2002

Drug/Important Bio-Agent (IBA)

12Aprepitant (Emend)FDA Link
02/2009 - 06/2002
6AntiemeticsIBA
05/2007 - 06/2002
5Ondansetron (Zofran)FDA LinkGeneric
10/2007 - 06/2002
5Cisplatin (Platino)FDA LinkGeneric
06/2005 - 06/2002
4Neurokinin-1 Receptor AntagonistsIBA
02/2009 - 06/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
02/2009 - 06/2003
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2003 - 06/2002
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
10/2004 - 03/2004
2Serotonin (5 Hydroxytryptamine)IBA
10/2004 - 06/2002
1SodiumIBA
08/2009
1Diphosphonates (Bisphosphonates)IBA
08/2009
1Alendronate (Alendronate Sodium)FDA LinkGeneric
08/2009
1Pharmaceutical PreparationsIBA
08/2009
1Tryptamines (Triptans)IBA
03/2009
1fosaprepitantFDA Link
07/2007
1EmeticsIBA
06/2005
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2004
1EtoricoxibIBA
08/2003
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2003
1Diclofenac (SR 38)FDA LinkGeneric
08/2003
1Ibuprofen (Motrin)FDA LinkGeneric
08/2003
1Naproxen (Naprosyn)FDA LinkGeneric
08/2003
1Cyclooxygenase InhibitorsIBA
08/2003
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
05/2003
1L 758298IBA
06/2002
1TabletsIBA
06/2002
1rizatriptan (Maxalt)FDA Link
01/2002

Therapy/Procedure

10Drug Therapy (Chemotherapy)
02/2009 - 05/2003
8Therapeutics
10/2007 - 06/2002
1General Anesthesia
05/2007